Skip to content
Homepage
Author:
Truveta
Posted Date:
June 29, 2026
New study examines real-world switching patterns after patients transition from Humira to biosimilars
Truveta
June 29, 2026
New study finds Shingrix vaccination rates rising rapidly among newly eligible adults, but disparities remain
Truveta
June 18, 2026
New study reveals major gaps in follow-up care for patients with heart failure
Truveta
May 28, 2026
Truveta and Knit Health announce collaboration to power a new generation of clinical AI
Truveta
May 27, 2026
Truveta unveils Truveta Intelligence, delivering real-time insights from real-world data
Truveta
May 25, 2026
Truveta deepens financial leadership with appointment of Henry Ford Health executive Robin Damschroder, FACHE as Board Chair
Truveta
May 21, 2026
Truveta deepens health system leadership with appointment of Erik Wexler to Board of Directors
Truveta
May 21, 2026
Truveta joins leading experts in calling for public utility framework to govern real-world health data
Truveta
April 30, 2026
FDA cardiovascular indication for semaglutide led to short-term uptake but persistent treatment gaps among high-risk patients, new Truveta study finds
Truveta
February 10, 2026
Truveta deepens regulatory science leadership with appointment of John D. Seeger, PharmD, DrPH, FISPE as Senior Vice President of Evidence Services
Truveta
February 9, 2026
1
2
Next
